Dulaglutide (Trulicity) clinical trials: 81 trials
Page 1 of 2
Read 81 Dulaglutide (Trulicity) clinical trials with posted results or linked papers with results in PepBank.
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT04255433 · Phase 3 · Completed
Posted results
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
NCT01394952 · Phase 3 · Completed
Posted results
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
NCT03495102 · Phase 3 · Completed
Posted results
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
NCT00734474 · Phase 2/3 · Completed
Posted results
- Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
NCT02648204 · Phase 3 · Completed
Posted results
- A Study in Participants With Type 2 Diabetes Mellitus
NCT01064687 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
NCT03684642 · Phase 3 · Terminated
Posted results
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
NCT01191268 · Phase 3 · Completed
Posted results
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
NCT01075282 · Phase 3 · Completed
Posted results
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
NCT01126580 · Phase 3 · Completed
Posted results
- A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
NCT01648582 · Phase 3 · Completed
Posted results
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
NCT01644500 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
NCT03861052 · Phase 3 · Completed
Posted results
- A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
NCT01624259 · Phase 3 · Completed
Posted results
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
NCT04809220 · Phase 3 · Completed
Posted results
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
NCT01621178 · Phase 3 · Completed
Posted results
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
NCT02787551 · Phase 3 · Completed
Posted results
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
NCT01558271 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
NCT03015220 · Phase 3 · Completed
Posted results
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
NCT02597049 · Phase 3 · Completed
Posted results
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
NCT01468181 · Phase 3 · Completed
Posted results
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
NCT01584232 · Phase 3 · Completed
Posted results
- A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
NCT03724981 · Phase 4 · Completed
Posted results
- A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
NCT02152371 · Phase 3 · Completed
Posted results
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
NCT01769378 · Phase 3 · Completed
Posted results
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
NCT04591626 · Phase 3 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
NCT05564039 · Phase 4 · Completed
Posted results
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
NCT05659537 · Phase 4 · Completed
Posted results
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
NCT02750410 · Phase 4 · Completed
Posted results
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
NCT02963766 · Phase 3 · Completed
Posted results
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
NCT04189848 · Phase 4 · Completed
Posted results
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
NCT06533527 · Phase 4 · Completed
Posted results
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
NCT03743025 · Phase 4 · Terminated
Posted results
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
NCT04387201 · Phase 4 · Completed
Posted results
- Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
NCT04862234 · Phase 4 · Terminated
Posted results
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
NCT03315780 · Phase 4 · Completed
Posted results
- A Study of IBI362 in Participants With Type 2 Diabetes
NCT05606913 · Phase 3 · Completed
Linked paper with results
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
NCT05680129 · Phase 3 · Completed
Linked paper with results
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
NCT03824002 · Phase 4 · Completed
Linked paper with results
- Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
NCT07325435 · Phase 4 · Active, not recruiting
Linked paper with results
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
NCT01149421 · Phase 2 · Completed
Posted results
- A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
NCT05048719 · Phase 2 · Completed
Posted results
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
NCT02973100 · Phase 2 · Completed
Posted results
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
NCT03131687 · Phase 2 · Completed
Posted results
- A Study of LY3437943 in Participants With Type 2 Diabetes
NCT04867785 · Phase 2 · Completed
Posted results
- A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
NCT00630825 · Phase 2 · Completed
Posted results
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
NCT00791479 · Phase 2 · Completed
Posted results
- A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
NCT01001104 · Phase 2 · Completed
Posted results
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
NCT05254418 · Phase 2 · Completed
Posted results
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
NCT03204396 · Phase 2 · Completed
Linked paper with results